Mercado de Biocirurgia Ásia-Pacífico – Tendências da Indústria e Previsão para 2028

Análise de mercado e insights do mercado de biocirurgia Ásia-Pacífico

A Data Bridge Market Research analisa que o mercado de biocirurgia Ásia-Pacífico apresentará um CAGR de cerca de 8,23% para o período de previsão de 2021-2028. O aumento da população geriátrica, o aumento do foco nas proficiências de investigação e desenvolvimento em relação aos dispositivos médicos e na adoção de tecnologias avançadas de saúde e o aumento das despesas no desenvolvimento da infraestrutura de saúde, especialmente nas economias em desenvolvimento, são os principais fatores atribuíveis ao crescimento do mercado da biocirurgia.

A biocirurgia é um procedimento cirúrgico que envolve a utilização de organismos vivos, como larvas ou vermes. Este antigo tratamento médico tem prevalecido até aos dias de hoje devido aos benefícios dele decorrentes. Os organismos comem a área infetada e o crescimento corporal prejudicial à saúde.

O aumento da consciencialização sobre os benefícios da biocirurgia em relação aos métodos cirúrgicos tradicionais são os principais fatores que impulsionam o crescimento do mercado. O crescente foco nos avanços tecnológicos em saúde para o desenvolvimento de produtos novos e avançados, juntamente com a crescente procura por cirurgias minimamente proeminentes, é outro determinante do crescimento do mercado. O aumento das proficiências em investigação e desenvolvimento, a crescente população geriátrica e o aumento da incidência de reconstrução articular e fusão espinhal irão gerar ainda mais oportunidades lucrativas de crescimento do mercado.

No entanto, as regulamentações rigorosas sobre as aprovações de produtos prejudicarão ainda mais a taxa de crescimento do mercado. O cenário de reembolso desfavorável nas economias em desenvolvimento e subdesenvolvidas representará ainda mais desafios para o mercado. As complicações associadas às cirurgias também prejudicarão a taxa de crescimento do mercado.

This Asia-Pacific biosurgery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Asia-Pacific biosurgery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Biosurgery Market Scope and Market Size

The Asia-Pacific biosurgery market is segmented on the basis of product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of product, the Asia-Pacific biosurgery market is segmented into bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers and staple-line reinforcement agents. The bone-graft substitutes are further sub-segmented into demineralized, bone matrix, synthetic bone grafts, bone morphogenetic proteins and others. The soft-tissue attachments segment can also be bifurcated into synthetic meshes and biological meshes. Hemostatic agents are further bifurcated into thrombin-based hemostatic agents, oxidized regenerated cellulose-based hemostatic agents, combination hemostatic and agents. Surgical sealants and adhesives can be also further sub-segmented into natural/biological sealants and adhesives types, natural/biological sealants and adhesives origin and synthetic and semi-synthetic sealants and adhesives.
• On the basis of application, the Asia-Pacific biosurg1ery market is segmented into general surgery, cardiovascular surgery, orthopedic surgery, neurological surgery, reconstructive surgery, gynecological surgery, thoracic surgery and urological surgery.

Asia-Pacific Biosurgery Market Country Level Analysis

The Asia-Pacific biosurgery market is analysed and market size insights and trends are provided by country, product and application as referenced above.

The countries covered in the biosurgery market report are Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific.

Asia-Pacific is projected to exhibit the highest growth rate during the forecast period owing to the increasing awareness about surgical procedures, ever-rising geriatric population, and increased expenditure for the development of healthcare infrastructure.  

The country section of the Asia-Pacific biosurgery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The Asia-Pacific biosurgery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific biosurgery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific biosurgery market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Asia-Pacific Biosurgery Market Share Analysis

The Asia-Pacific biosurgery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Asia-Pacific biosurgery market.

The major players covered in the Asia-Pacific biosurgery market report are BD, Baxter., Medical Devices Business Services, Inc., B. Braun Melsungen AG, CryoLife, Inc., Johnson & Johnson Services, Inc., Medtronic, Sanofi, Stryker, Hemostasis, LLC., Integra LifeSciences Corporation., Pfizer Inc., CSL Limited, Exactech, Inc., RTI Surgical, MAQUET Holding B.V. & Co. KG, SAMYANG BIOPHARMACEUTICALS CORPORATION., Aroa Biosurgery Limited, TELA Bio, Inc., Tissue Regenix, Osiris and Biosurge Healthcare India Private Limited among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-1975